patent/DO-P2018000027-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30
filingDate	2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56ee2b09412a2a2d07b242d9650616fb
publicationDate	2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	DO-P2018000027-A
titleOfInvention	INHIBITOR OF MUTED DEHYDROGENASE ISOCITRATE IDH1 R132H
abstract	The present invention relates to adductive acid (2E) -but-2-enedioic acid and 3- (2 - {[4- (trifluoromethoxy) phenyl] amino} -1 - [(1R, 5R) -3,3,5 -trimethylcyclohexyl] -1H-benzimidazol-5-yl) propanoic acid (1: 4), to methods for preparing this adduct, compositions comprising this adduct, and also to the use of this adduct to prepare a medicament for the treatment of a disease.
priorityDate	2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118310260 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460172 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433441519 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID723 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538597 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3417 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589651

Total number of triples: 24.